loadpatents
name:-0.011975049972534
name:-0.013113021850586
name:-0.0020308494567871
WEICHSEL; Aleksandra Patent Filings

WEICHSEL; Aleksandra

Patent Applications and Registrations

Patent applications and USPTO patent grants for WEICHSEL; Aleksandra.The latest application filed is for "acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals".

Company Profile
0.11.10
  • WEICHSEL; Aleksandra - Tucson AZ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Acylamino-substituted Fused Cyclopentanecarboxylic Acid Derivatives And Their Use As Pharmaceuticals
App 20160272577 - SCHAEFER; Matthias ;   et al.
2016-09-22
Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals
Grant 9,328,071 - Schaefer , et al. May 3, 2
2016-05-03
Cycloalkane carboxylic acid derivatives as CXCR3 receptor antagonists
Grant 9,073,853 - Bata , et al. July 7, 2
2015-07-07
Acylamino-substituted Fused Cyclopentanecarboxylic Acid Derivatives And Their Use As Pharmaceuticals
App 20140309264 - SCHAEFER; Matthias ;   et al.
2014-10-16
Cycloalkane Carboxylic Acid Derivatives As Cxcr3 Receptor Antagonists
App 20140288106 - BATA; Imre ;   et al.
2014-09-25
Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals
Grant 8,802,720 - Schaefer , et al. August 12, 2
2014-08-12
Acylamino-substituted Fused Cyclopentanecarboxylic Acid Derivatives And Their Use As Pharmaceuticals
App 20130225605 - SCHAEFER; Matthias ;   et al.
2013-08-29
CXCR2 inhibitors
Grant 8,501,981 - Hachtel , et al. August 6, 2
2013-08-06
Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals
Grant 8,445,530 - Schaefer , et al. May 21, 2
2013-05-21
Acylamino-substituted Fused Cyclopentanecarboxylic Acid Derivatives And Their Use As Pharmaceuticals
App 20130030008 - SCHAEFER; Matthias ;   et al.
2013-01-31
Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals
Grant 8,362,073 - Schaefer , et al. January 29, 2
2013-01-29
CXCR2 inhibitors
Grant 8,283,479 - Hachtel , et al. October 9, 2
2012-10-09
Cxcr2 Inhibitors
App 20110184177 - Hachtel; Stephanie ;   et al.
2011-07-28
Acylamino-substituted Fused Cyclopentanecarboxylic Acid Derivatives And Their Use As Pharmaceuticals
App 20110152290 - SCHAEFER; Matthias ;   et al.
2011-06-23
CXCR2 inhibitors
Grant 7,919,628 - Hachtel , et al. April 5, 2
2011-04-05
Cxcr2 Inhibitors
App 20090227625 - HACHTEL; Stephanie ;   et al.
2009-09-10
Cxcr2 Inhibitors
App 20080090854 - HACHTEL; Stephanie ;   et al.
2008-04-17
Triaza- and tetraaza-anthracenedione derivatives, their preparation and their use as pharmaceuticals
Grant 7,132,536 - Weichert , et al. November 7, 2
2006-11-07
Triaza- and tetraaza-anthracenedione derivatives, their preparation and their use as pharmaceuticals
App 20040248900 - Weichert, Andreas ;   et al.
2004-12-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed